These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 18492887)
1. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent". Runge VM AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887 [No Abstract] [Full Text] [Related]
2. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)]. Heuck A; Reiser M Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330 [No Abstract] [Full Text] [Related]
3. Gadolinium and kidney disease: are your patients at risk? Hollister D Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687 [No Abstract] [Full Text] [Related]
4. Tolerability of gadobenate dimeglumine in a patient with reported allergy to gadoterate meglumine. Moulin C; Said BB; Berard F AJR Am J Roentgenol; 2011 Dec; 197(6):W1163. PubMed ID: 22109336 [No Abstract] [Full Text] [Related]
5. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467 [TBL] [Abstract][Full Text] [Related]
9. Renal failure and gadolinium. The number of documented cases is rising. Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311 [No Abstract] [Full Text] [Related]
10. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography? Brown RR; Clarke DW; Daffner RH AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170 [TBL] [Abstract][Full Text] [Related]
11. Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis. Kefalas CH; Murray NG; Aguanno JJ; Dockery WD; Weinstein JS; Anderson K; Klintmalm GB Liver Transpl; 2004 Jan; 10(1):136-40. PubMed ID: 14755791 [TBL] [Abstract][Full Text] [Related]
12. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat. Haylor J; Dencausse A; Vickers M; Nutter F; Jestin G; Slater D; Idee JM; Morcos S Invest Radiol; 2010 Sep; 45(9):507-12. PubMed ID: 20697223 [TBL] [Abstract][Full Text] [Related]
13. A horse-riding accident and haemolytic anaemia. Bittle CC Lancet; 2004 Nov 6-12; 364(9446):1728. PubMed ID: 15530636 [No Abstract] [Full Text] [Related]
15. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Thomsen HS; Morcos SK; Dawson P Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301 [No Abstract] [Full Text] [Related]
16. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784 [TBL] [Abstract][Full Text] [Related]